We are live on
!
Find out more
CA
Commerzbank Aktiengesellschaft Portfolio holdings
AUM
$4.78B
1-Year Est. Return
25.31%
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
+25.31%
3 Year Est. Return
+83.81%
5 Year Est. Return
+102.52%
10 Year Est. Return
+396.32%
AUM
$19.6B
AUM Growth
-$3.64B
(-16%)
Cap. Flow
-$4.8B
Cap. Flow
% of AUM
-24.53%
Top 10 Holdings %
Top 10 Hldgs %
30.47%
Holding
1,281
New
93
Increased
457
Reduced
541
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$191M |
| 2 |
Deutsche Bank
DB
|
+$165M |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$108M |
| 4 |
Citigroup
C
|
+$101M |
| 5 |
MON
Monsanto Co
MON
|
+$88.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.62B |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$506M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$341M |
| 4 |
Apple
AAPL
|
+$340M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.11% |
| 2 | Technology | 13.96% |
| 3 | Healthcare | 7.4% |
| 4 | Communication Services | 6.97% |
| 5 | Consumer Discretionary | 5.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Teva Pharmaceuticals
TEVA
$40.2B
| $2.31M | 0.01% |
44,124
+15,911
| +56% | +$813K |
|
677
Cincinnati Financial
CINF
$27.7B
| $2.31M | 0.01% |
48,124
-3,002
| -6% | -$146K |
|
678
CALL
JPMorgan Chase
JPM
$919B
| $2.31M | 0.01% |
+40,000
| New | +$2.25M |
|
679
CALL
Wynn Resorts
WYNN
$10.2B
| $2.3M | 0.01% |
11,100
| – | – |
|
680
Pitney Bowes
PBI
$2.4B
| $2.27M | 0.01% |
82,216
+32,697
| +66% | +$871K |
|
|
CFN
681
DELISTED
CAREFUSION CORPORATION
CFN
| $2.26M | 0.01% |
50,931
-5,171
| -9% | -$214K |
|
682
CALL
Applied Materials
AMAT
$350B
| $2.25M | 0.01% |
+100,000
| New | +$2.04M |
|
683
Edwards Lifesciences
EW
$49.3B
| $2.23M | 0.01% |
155,628
-16,812
| -10% | -$228K |
|
684
PUT
Pfizer
PFE
$143B
| $2.23M | 0.01% |
79,050
| – | – |
|
|
OCR
685
DELISTED
OMNICARE INC
OCR
| $2.22M | 0.01% |
33,369
+1,334
| +4% | +$82.9K |
|
686
News Corp Class A
NWSA
$15.6B
| $2.22M | 0.01% |
123,617
-5,612
| -4% | -$96.9K |
|
|
HBI
687
DELISTED
Hanesbrands
HBI
| $2.18M | 0.01% |
+88,612
| New | +$1.83M |
|
688
Hasbro
HAS
$13.5B
| $2.18M | 0.01% |
41,043
+8,729
| +27% | +$472K |
|
689
Equifax
EFX
$22B
| $2.17M | 0.01% |
29,897
-2,804
| -9% | -$197K |
|
690
Waters Corp
WAT
$37.1B
| $2.16M | 0.01% |
20,719
-2,149
| -9% | -$226K |
|
|
NE
691
DELISTED
Noble Corporation
NE
| $2.16M | 0.01% |
84,361
-7,108
| -8% | -$195K |
|
692
International Flavors & Fragrances
IFF
$20.3B
| $2.16M | 0.01% |
20,674
-1,918
| -8% | -$189K |
|
693
Everest Group
EG
$15.5B
| $2.15M | 0.01% |
13,429
+707
| +6% | +$112K |
|
694
United Therapeutics
UTHR
$26.2B
| $2.15M | 0.01% |
24,302
+12,750
| +110% | +$1.23M |
|
|
ARNA
695
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.15M | 0.01% |
36,598
+188
| +0.5% | +$11.8K |
|
|
AOL
696
DELISTED
AOL INC COMMON STOCK
AOL
| $2.14M | 0.01% |
53,794
-65,844
| -55% | -$2.59M |
|
697
Labcorp
LH
$25.1B
| $2.12M | 0.01% |
24,125
-2,591
| -10% | -$224K |
|
698
CALL
BP
BP
$112B
| $2.11M | 0.01% |
+48,902
| New | +$2.02M |
|
|
VAR
699
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.11M | 0.01% |
28,935
-2,778
| -9% | -$200K |
|
|
HSP
700
DELISTED
HOSPIRA INC
HSP
| $2.1M | 0.01% |
40,878
-3,622
| -8% | -$172K |
|
Similar funds
MP
WAM
GAM
MF
RC
JSTA
TPCW
Commerzbank Aktiengesellschaft's Q2 2014 Portfolio in Review
As of Q2 2014, Commerzbank Aktiengesellschaft held 1,281 positions worth $19.6B, down 16% from $23.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Commerzbank Aktiengesellschaft withdrew a net $4.8B in Q2 2014, closing 99 positions and reducing 541 holdings. Its most notable exit was VanEck Oil Services ETF, an estimated $101M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Commerzbank Aktiengesellschaft opened a new position in INTERMUNE INC worth $20M.
- Commerzbank Aktiengesellschaft's largest Q2 2014 buy was INTERMUNE INC: 451,954 shares worth $20M.
- Commerzbank Aktiengesellschaft added most to Invesco QQQ Trust in Q2 2014, an estimated $191M increase.
- Commerzbank Aktiengesellschaft's biggest Q2 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.62B.
- Commerzbank Aktiengesellschaft fully exited VanEck Oil Services ETF in Q2 2014, selling an estimated $101M.
- Commerzbank Aktiengesellschaft's ten largest holdings make up 30% of its $19.6B portfolio in Q2 2014.
- Commerzbank Aktiengesellschaft opened 93 new positions and closed 99 in Q2 2014.
- Commerzbank Aktiengesellschaft's portfolio value fell 16% quarter-over-quarter to $19.6B.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2014, filed 12 Aug 2014.